VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COCP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COCPCocrystal Pharma, Inc.
$1.03$11M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCOCPEarnings History

COCP logoCocrystal Pharma, Inc. (COCP) Earnings History

Net Loss

19 years of earnings data (2007–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$9M
● Net Loss
TTM EPS (Diluted)
$-0.64
Per share, diluted
YoY EPS Growth
+54.7%
Excellent
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity-111.4%
Return on Assets-76.2%
Record Annual Net Income-$41,370FY2009
Record Quarterly EPS$13.97Q2 2014
Consecutive Profitable Years0years
Q1 2026
Net Income-$2M
EPS (Diluted)$-0.17
YoY Growth+54.7%Excellent
QoQ Growth+5.2%Solid

Loading earnings history...

Cocrystal Pharma, Inc. (COCP) Earnings Overview

As of June 30, 2026, Cocrystal Pharma, Inc. (COCP) reported trailing twelve-month net income of -$9M, reflecting +54.7% year-over-year growth. The company earned $-0.64 per diluted share over the past four quarters.

Looking at the long-term picture, COCP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$41,370 in fiscal 2009.

Cocrystal Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including AGEN ($65M net income, 0.1% margin), ABUS ($161M net income, -237.9% margin), RDVT ($14M net income, 14.6% margin), COCP has comparable earnings metrics. Compare COCP vs AGEN →

COCP Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
COCP logoCOCPCurrent
-$9M$-0.64--111.4%+54.7%—
AGEN logoAGEN
$65M$1.690.1%-+100.0%
ABUS logoABUS
$161M$0.82-237.9%-38.5%+55.3%
RDVT logoRDVT
$14M$0.9814.6%14.0%+82.0%
RLAY logoRLAY
-$273M$-1.52-1800.6%-41.1%+31.8%
GILD logoGILD
$9.2B$7.3528.9%40.7%+1684.2%
Best in group
Lowest in group

COCP Historical Earnings Data (2007–2025)

19 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$9M+49.5%-$9M$-0.78--
2024-$18M+2.7%-$18M$-1.72--
2023-$18M+53.7%-$19M$-0.00--
2022-$39M-173.8%-$39M$-4.77--
2021-$14M-47.0%-$14M$-1.85--
2020-$10M+80.0%-$10M$-2.01-479.0%-476.0%
2019-$48M+1.8%-$48M$-15.78-733.8%-737.4%
2018-$49M-7901.3%-$63M$-21.01--
2017$-613,000+99.2%-$8M$-0.30--
2016-$75M-49.4%-$106M$-38.14--
2015-$50M-50528.3%-$54M$-28.60-64259.0%-69164.1%
2014$-99,000+99.5%-$6M$-0.29-1100.0%-64433.3%
2013-$20M-146.4%-$3M$-62.00--
2012-$8M-45.9%-$3M$-45.41-46.3%-15.3%
2011-$5M-11157.3%-$4M$-35.60-43.3%-30.8%
2010$-48,478-17.2%$-49,493$-0.39--
2009$-41,370+21.8%$-42,848$-0.40--
2008$-52,917+9.9%$-55,854$-0.51--
2007$-58,723-$-61,524$-0.62--

Download Data

Export COCP earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

19+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

COCP — Frequently Asked Questions

Quick answers to the most common questions about buying COCP stock.

What is COCP earnings per share (EPS)?

COCP trailing twelve-month (TTM) diluted EPS is $-0.64, reflecting +54.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2007 to 2025 is available in the table on this page.

What is Cocrystal Pharma, Inc.'s net income?

Cocrystal Pharma, Inc. (COCP) trailing twelve-month net income is $-9M as of 2025. Earnings grew +54.7% year-over-year.

Is COCP profitable?

COCP is not currently profitable on a TTM basis, reporting a net loss of $-9M. Net margin is N/A. Investors should monitor for a return to profitability.

What is COCP's earnings growth rate?

COCP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.

What are COCP's profit margins?

Cocrystal Pharma, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -111.4%.

Is COCP growing earnings?

Yes, COCP earnings are accelerating — EPS growth of +54.7% exceeds the 5-year CAGR of N/A. TTM net income reached $-9M. Earnings momentum is strengthening.

What was COCP's best earnings year?

Cocrystal Pharma, Inc.'s highest annual net income on record is $-41370.00, achieved in fiscal year 2009. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.

What were COCP's earnings last quarter?

COCP's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.17. For a full breakdown of all quarters, see the quarterly earnings table on this page.

COCP Earnings Over Time (2007–2025)

Net income & EPS — annual and quarterly view